Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Trading Update

6 Jan 2005 07:00

Torex Retail PLC06 January 2005 6 January 2005 TOREX RETAIL PLC TRADING UPDATE Torex Retail plc ("Torex Retail" or "the Group"), the UK's market leader inretail IT solutions, is pleased to announce that following the close of its yearend on 31 December 2004, it expects to report pre-tax profits ahead ofexpectations when it announces its preliminary results in February 2005. This reflects strong trading from all areas of the Group. The success of theGroup in the second half of 2004 is based upon sales of Group software productswith associated services, particularly with new contract wins for its marketleading EpoS product LUCAS. This has reinforced the changing business modelexperienced in the first half with increased software licence sales and lowerhardware revenues contributing to improved operating margins. In addition atight control on working capital has resulted in a strong cash inflow fromoperating activities. The integration of Alphameric Retail has commenced and initial findings areconsistent with pre-acquisition due diligence and the strategic rationale forthe transaction. In addition, new opportunities are being identified which isvery encouraging for 2005 and beyond. Rob Loosemore, Chairman of Torex Retail plc, commented: "I am delighted with the progress we have made in our first year as a publiccompany both in terms of financial performance and strategic development.Strong trading, particularly in the second half, together with the acquisitionof Alphameric's Retail Division provides a tremendous platform and momentum fororganic growth in 2005 and beyond. The pre-tax profits will be ahead ofexpectations which continues the long established tradition of the seniormanagement team, of not only doing what we say we will do but exceeding it." Enquiries: Torex Retail plc Citigate Dewe Rogerson Mark Pearman, Chief Executive Ginny Pulbrook / Seb Hoyle / Freida Moore Richard Thompson, Finance Director Telephone: +44 (0)20 7638 9571 Telephone: +44 (0)870 050 9900 Notes to Editors: Torex Retail, a leading European retail solutions business, floated on AIM inMarch 2004. The business is an independent supplier of electronic point of sale("EPOS") solutions and services and productivity tools to high street,convenience and petroleum retailers with an installed base of some 50,000 EPOSlicences across Europe. It has a broad base of blue-chip clients and employs700 staff in UK, Germany, Belgium, Holland and Eire. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Nov 20227:00 amRNSDistribution agreement - OrthoPure® XT in Germany
14th Nov 20226:05 pmRNSHolding(s) in Company
7th Nov 20222:35 pmRNSHolding(s) in Company
29th Sep 202210:13 amRNSDirector/PDMR Shareholding
27th Sep 20227:15 amEQSHardman & Co Research on Tissue Regenix (TRX): Operating leverage
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20223:31 pmRNSHolding(s) in Company
18th Aug 20225:36 pmRNSHolding(s) in Company
18th Aug 20222:10 pmRNSHolding(s) in Company
11th Aug 20224:30 pmEQSHardman & Co Research: Q&A on Tissue Regenix Group plc: Significantly undervalued which should correct
11th Aug 202212:46 pmRNSHolding(s) in Company
11th Aug 202212:17 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSConfirmation of Interim Results
5th Aug 20223:19 pmRNSHolding(s) in Company
1st Aug 20223:14 pmRNSHolding(s) in Company
19th Jul 20222:30 pmEQSHardman & Co Research : Tissue Regenix (TRX): Strong 1H’22 sales suggest upside potential
19th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
18th Jul 20222:42 pmRNSHolding(s) in Company
18th Jul 20221:33 pmRNSHolding(s) in Company
15th Jul 20225:29 pmRNSHolding(s) in Company
27th Jun 20226:04 pmRNSHolding(s) in Company
27th Jun 202212:58 pmRNSHolding(s) in Company
16th Jun 20221:27 pmRNSExercise of Options and Total Voting Rights
28th Apr 20227:00 amRNSOrthoPure®XT clinical results presentation
26th Apr 20224:19 pmRNSResult of AGM
20th Apr 20224:26 pmRNSDirector/PDMR Shareholding
19th Apr 20227:15 amEQSHardman & Co Research: Tissue Regenix (TRX) On pathway to sustainability
8th Apr 20227:00 amRNSGrant of share options
6th Apr 20222:59 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSFinal year results for the year ended 31 Dec 2021
9th Mar 20227:00 amRNSDistribution agreement for OrthoPure® XT
2nd Mar 20227:00 amRNSNotice of Results
10th Feb 20223:45 pmRNSAdditional Director Disclosures
27th Jan 20227:00 amRNSFull Year Trading update
23rd Dec 20217:00 amRNSDirector/PDMR Shareholding
21st Dec 20212:06 pmRNSSecond Price Monitoring Extn
21st Dec 20212:01 pmRNSPrice Monitoring Extension
19th Oct 20211:15 pmEQSHardman & Co Research: Tissue Regenix (TRX): Faster-than-anticipated recovery
8th Oct 20217:00 amRNSHolding(s) in Company
5th Oct 20214:44 pmRNSHolding(s) in Company
28th Sep 20217:00 amRNSHolding(s) in Company
24th Sep 20212:05 pmRNSDirector/PDMR Shareholding
9th Sep 20214:35 pmRNSDirector/PDMR Shareholding
8th Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSLaunch of DermaPure® Meshed and VNEWTM
1st Sep 20217:00 amRNSNotice of Results
16th Aug 20217:00 amRNSHolding(s) in Company
14th Jul 20213:15 pmEQSHardman & Co Research: Q&A with Dr Martin Hall on Tissue Regenix Group Plc: New capacity now on stream
30th Jun 202111:56 amEQSHardman & Co Research: Tissue Regenix (TRX): Poised for growth
29th Jun 20211:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.